Atlas Trials

Study Evaluating the Safety and Efficacy of Etanercept in Patients With Idiopathic Pulmonary Fibrosis

Clinical trial NCT00063869 · COMPLETED

Trial details

NCT number
NCT00063869
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pulmonary Fibrosis
Primary completion
2005-03-01
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.